Advertisement

Pain General

April 2019 Briefing - Pain Management

May 01, 2019

Here are what the editors at HealthDay consider to be the most important developments in Pain Management for April 2019. This roundup includes the latest research news from journal articles, as well a...

Teva stops testing its migraine drug as cluster headache treatment

Apr 23, 2019

By Manas Mishra (Reuters) - Teva Pharmaceutical Industries Ltd said on Tuesday it would stop developing its migraine drug, Ajovy, for treating cluster headaches after the ...

FDA approves Teva's generic nasal spray to treat opioid overdose

Apr 19, 2019

(Reuters) - Generic drugmaker Teva Pharmaceutical Industries Ltd on Friday received approval from the U.S. Food and Drug Administration (FDA) to market its generic nasal spray for opioi...

Acetaminophen Safe as First-Line Analgesic for Most Older Adults

Apr 19, 2019

FRIDAY, April 19, 2019 (HealthDay News) -- Despite a potential increased risk for stroke in patients with diabetes, acetaminophen is a safe first-line analgesic for most older adults living in nursing...

U.S. launches four-state study to find ways to reduce opioid overdose deaths

Apr 18, 2019

By Manas Mishra and Tamara Mathias (Reuters) - U.S. health officials on Thursday said they will spend $350 million in four states to study ways to best deal with the natio...

Lower dose of Pfizer-Lilly painkiller misses main goals in late stage study

Apr 18, 2019

(Reuters) - A lower dose of non-opioid painkiller developed by Pfizer Inc and Eli Lilly and Co failed to meet main goals in a late-stage study in patients with moderate-to-severe osteoa...

Curbing Long-term Opioid Use: The Case for Early Physical Therapy

Apr 18, 2019

Early physical therapy (PT) may help reduce the risk of long-term opioid use by serving as an alternative or adjunct to short-term opioid use for patients with various types of musculoskeletal pain. P...

Sixty People Charged in Massive Opioid Painkiller Investigation

Apr 18, 2019

THURSDAY, April 18, 2019 (HealthDay News) -- Fifty-three medical professionals, including 31 doctors, are among the 60 people charged by U.S. authorities for their alleged involvement in the illegal p...

Dozens of doctors in Appalachia charged in opioid fraud bust

Apr 17, 2019

By Gabriella Borter (Reuters) - Dozens of medical professionals in Appalachia, a region hard-hit by the U.S. opioid crisis, have been charged with writing hundreds of thou...

Barriers to Opioid Use Disorder Treatment Should Be Addressed

Apr 16, 2019

TUESDAY, April 16, 2019 (HealthDay News) -- Barriers to accessing treatment for opioid use disorder (OUD) need to be addressed to help curb the epidemic, according to a report published by the Nationa...

Cannabis users may need more anesthesia for surgery

Apr 15, 2019

By Lisa Rapaport (Reuters Health) - People who regularly use cannabis may need more than twice the usual dose of anesthesia for surgery, a U.S. study suggests. ...

In Pregnancy, Buprenorphine Use Up, Methadone Use Down

Apr 12, 2019

FRIDAY, April 12, 2019 (HealthDay News) -- From 2009 to 2015, the prevalence of methadone use decreased and buprenorphine use increased among Medicaid-enrolled pregnant women with opioid use disorder,...

CDC Clarifies Guideline on Opioid Prescribing for Chronic Pain

Apr 12, 2019

FRIDAY, April 12, 2019 (HealthDay News) -- The U.S. Centers for Disease Control and Prevention has clarified that the new guideline on prescribing opioids for chronic pain is not meant to limit access...

Indivior shares plummet, Reckitt hurt on U.S. charges over opioid prescriptions

Apr 11, 2019

(This April 10 story refiles to fix scrambled syntax in paragraph five) By Justin George Varghese and Martinne Geller (Reuters) - British drugmaker Indivior...

Peripheral Nerve Block May Cut Opioid Use After Amputation

Apr 10, 2019

WEDNESDAY, April 10, 2019 (HealthDay News) -- Peripheral nerve blockade with regular local anesthetic and liposomal bupivacaine is associated with lower oral morphine equivalent (OME) use at 72 hours ...

FDA: Patients Should Not Abruptly Stop Taking a Prescribed Opioid

Apr 10, 2019

WEDNESDAY, April 10, 2019 (HealthDay News) -- Because of the danger of "serious harm" to patients, the U.S. Food and Drug Administration is advising doctors not to suddenly stop patients from taking o...

Physical Medicine & Rehabilitation: The Unknown Specialty

Apr 09, 2019

As a family physician in private practice, our Editor in Chief, Linda Girgis, MD, understands what it means to practice in a vast area of medicine. While physicians will always juggle the challenges o...

Exclusive: Pain-care specialist agrees to testify against Purdue, other drug makers - court documents

Apr 07, 2019

By Lisa Girion and Maria Caspani (Reuters) - A physician ally of Purdue Pharma LP whose views helped drive the explosive growth in the use of addictive pain relievers for ...

Oklahoma drops several claims in opioid case against J&J, Teva

Apr 04, 2019

By Nate Raymond (Reuters) - Oklahoma's attorney general on Thursday had dropped all but a single claim against Johnson & Johnson and Teva Pharmaceutical Industries Ltd...

Novartis, Amgen in dispute over migraine drug partnership

Apr 04, 2019

By Jonathan Stempel and Deena Beasley NEW YORK/LOS ANGELES (Reuters) - Swiss drugmaker Novartis AG sued Amgen Inc on Thursday, accusing the U.S. biotechnology company of t...

SUBSPECIALTIES

Advertisement